Cancer Imaging System Market, By Imaging Modality (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography (PET), Ultrasound, and Mammography), By Application, By End-user, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4187
|
Published Date
July 2025
|
Pages
387
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Cancer Imaging System Market size was valued at US$ 21,987.24 Million in 2024, expanding at a CAGR of 9.5% from 2025 to 2032.
The Cancer Imaging System market encompasses the global industry dedicated to technologies and equipment used for detecting, diagnosing, and monitoring cancer through medical imaging. Key imaging modalities in this market include Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography (PET), ultrasound, and mammography. These systems are essential for early cancer detection, accurate staging, treatment planning, and assessing the effectiveness of therapies. Market growth is driven by several factors, including the rising global prevalence of cancer, increased awareness of the benefits of early diagnosis, and continuous advancements in imaging technologies. Innovations such as AI-powered image interpretation, hybrid imaging systems, and molecular imaging are enhancing diagnostic precision and improving clinical outcomes.
Government initiatives and investments in cancer screening programs across the globe are also boosting demand for advanced imaging solutions. Additionally, the aging population and increasing incidence of lifestyle-related cancers are contributing to the market\'s expansion. Despite these positive trends, challenges such as the high cost of imaging equipment and limited access to advanced technologies in low-income regions continue to hinder broader adoption. Nevertheless, the cancer imaging system market is evolving rapidly, playing a critical role in the advancement of precision oncology and patient-centered care.
Cancer Imaging System Market- Market Dynamics
Radiomics: Enabling Personalized Cancer Imaging Through Data-Driven Tumor Insights
A niche yet impactful driver in the Cancer Imaging System market is the growing adoption of radiomics for personalized oncology. Radiomics involves extracting large volumes of quantitative data from medical images using advanced computational algorithms. This data reveals subtle tumor characteristics—such as shape, texture, and intensity—that are often invisible to the human eye. By providing insights into tumor heterogeneity, radiomics helps predict treatment response and improves prognostic accuracy. As precision medicine continues to evolve, radiomics is becoming increasingly important for tailoring cancer treatments to individual patients. It offers a non-invasive method for understanding tumor biology, potentially reducing the need for repeated biopsies. The integration of radiomics with artificial intelligence further enhances its capability to identify complex patterns and correlations, supporting clinical decision-making and accelerating research in cancer therapeutics. Its use is expanding across imaging modalities such as CT, MRI, and PET scans.
Governments worldwide are also recognizing the value of advanced imaging and data-driven oncology. For instance, the U.S. National Cancer Institute (NCI) and the European Union\'s Horizon Europe program are funding large-scale radiomics research initiatives aimed at improving cancer diagnosis and treatment outcomes. Such investments are further driving adoption and innovation in the field. With a growing global emphasis on personalized and data-driven healthcare, radiomics is poised to play a transformative role in future cancer imaging strategies.
Cancer Imaging System Market- Segmentation Analysis:
The Global Cancer Imaging System Market is segmented on the basis of Imaging Modality, Application, End-user, and Region.
The Cancer Imaging System market is segmented based on imaging modality into Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography (PET), Ultrasound, Mammography, and Others. Among these, MRI stands out as the most dominant segment due to its exceptional soft tissue contrast and ability to produce highly detailed images without the use of ionizing radiation. MRI plays a critical role in detecting and staging a wide range of cancers, including brain, breast, prostate, and liver cancers. It also supports advanced functional imaging techniques such as diffusion-weighted imaging and magnetic resonance spectroscopy, which improve tumor characterization and aid in treatment planning and monitoring. The growing global demand for non-invasive, highly precise diagnostic tools—driven by rising cancer incidence—and ongoing technological advancements have further solidified MRI\'s leading position in the market. According to the International Agency for Research on Cancer (IARC), the global cancer burden reached 19.3 million new cases and 10 million deaths in 2020, underscoring the urgent need for advanced imaging solutions. In response, many governments are investing heavily in modern diagnostic infrastructure, with countries such as the U.S., Germany, Japan, and China expanding MRI accessibility through public healthcare programs and subsidies.
The market is also categorized by application into Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, and Others. Among these, breast cancer is the most dominant segment, primarily due to its high global prevalence and the vital importance of early detection for effective treatment. Imaging modalities like mammography and MRI are extensively employed for accurate diagnosis, staging, and monitoring of breast cancer. Government-led screening programs and rising awareness initiatives play a crucial role in increasing the uptake of imaging systems worldwide. The World Health Organization (WHO) reported that breast cancer became the most commonly diagnosed cancer globally in 2020, accounting for 2.3 million new cases—representing 11.7% of all cancer cases. Many countries, including the United Kingdom, Canada, Australia, and several in the European Union, have implemented national breast cancer screening programs, offering routine mammograms for women over a certain age. These efforts, combined with advancements in imaging technologies that allow the detection of smaller and earlier-stage tumors, significantly enhance treatment outcomes and continue to drive substantial growth in the breast cancer imaging segment.
Cancer Imaging System Market- Geographical Insights
North America holds a leading position in the global Cancer Imaging System market, driven by high cancer prevalence, advanced healthcare infrastructure, and substantial investment in medical technology. The United States dominates the region, with widespread adoption of advanced imaging modalities such as MRI, CT, PET, and hybrid imaging systems. The integration of artificial intelligence in diagnostic workflows and a strong focus on early detection significantly contribute to market growth. Supportive government initiatives further strengthen the U.S. market. Programs such as the Cancer Moonshot, which aims to accelerate cancer research and improve access to care, and the expansion of Medicare coverage for cancer screening procedures have made advanced imaging more accessible to patients. Canada also plays a vital role, with increasing cancer screening initiatives and improved access to modern imaging technologies across provinces.
Globally, governments are investing in cancer imaging and personalized diagnostics. For example, the European Union’s Horizon Europe research framework allocates funding for AI and radiomics in oncology, while the World Health Organization continues to support cancer screening infrastructure in low- and middle-income countries. These initiatives reflect a growing international commitment to enhancing cancer care through early detection and precision imaging. Together, these efforts underscore North America’s dominant role in the market and highlight the broader global momentum toward improving cancer outcomes through advanced imaging technologies.
Cancer Imaging System Market- Competitive Landscape:
The competitive landscape of the Cancer Imaging System market is marked by the presence of numerous global and regional players offering a diverse range of imaging solutions. Industry leaders such as GE HealthCare, Siemens Healthineers, and Philips Healthcare dominate the market with extensive imaging portfolios, robust research and development capabilities, and a strong global footprint. These companies are at the forefront of innovation, integrating advanced technologies including artificial intelligence (AI), radiomics, and next-generation software to enhance diagnostic accuracy and workflow efficiency.
Mid-tier players like Canon Medical and Fujifilm compete by leveraging niche technologies and forming strategic partnerships to expand their market presence. Meanwhile, startups and emerging firms are increasingly entering the space, offering AI-driven imaging solutions specifically tailored for oncology, contributing to a dynamic and evolving competitive environment. The market remains highly competitive, with companies investing heavily in regulatory approvals, collaborative efforts with cancer research institutions, and global expansion strategies. Technological advancements—particularly in hybrid imaging systems and molecular diagnostics—are reshaping market dynamics and driving product differentiation. In addition to innovation, factors such as pricing strategies, comprehensive service offerings, and post-installation support play a crucial role in influencing competitive positioning. The growing focus on personalized medicine and early cancer detection continues to spur innovation and intensify competition among key players.
Recent Developments:
-
December 2024: Guardant Health, Inc. announced a strategic partnership with Boehringer Ingelheim to advance the regulatory approval and commercialization of the Guardant360 CDx liquid biopsy. This collaboration centers on using the test as a companion diagnostic (CDx) for zongertinib, a novel covalent tyrosine kinase inhibitor (TKI) designed to selectively target HER2 while minimizing off-target effects on the epidermal growth factor receptor (EGFR) in patients with non-small cell lung cancer (NSCLC).
-
November 2024: Danaher Corporation unveiled plans to establish two new Centers of Innovation in Diagnostics to accelerate advancements in precision medicine. The first center, located in Newcastle, UK, is scheduled to open in July 2025 and will function as a collaborative research hub involving top pharmaceutical and academic institutions. Operated by Danaher’s subsidiary Leica Biosystems, the facility will be Danaher’s first CLIA CAP-certified laboratory, focused on pushing the boundaries of diagnostic research and clinical applications.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CANCER IMAGING SYSTEM MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- GE HealthCare
- Siemens Healthineers
- Philips Healthcare
- Canon Medical Systems
- Fujifilm Holdings
- Hologic Inc.
- Bracco Imaging
- Carestream Health
- Esaote SpA
- Shimadzu Corporation
- Samsung Medison
- United Imaging Healthcare
- PerkinElmer Inc.
- Agfa-Gevaert Group
- Konica Minolta Healthcare
- Mindray Medical International
- Neusoft Medical Systems
- ViewRay Inc.
- Hyperfine Inc.
- Median Technologies
GLOBAL CANCER IMAGING SYSTEM MARKET, BY IMAGING MODALITY- MARKET ANALYSIS, 2019 - 2032
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
- Positron Emission Tomography (PET)
- Ultrasound
- Mammography
- Others
GLOBAL CANCER IMAGING SYSTEM MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Liver Cancer
- Others
GLOBAL CANCER IMAGING SYSTEM MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Diagnostic Imaging Centers
- Specialty Clinics
- Academic and Research Institutes
GLOBAL CANCER IMAGING SYSTEM MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Cancer Imaging System Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Cancer Imaging System Market Snippet by Imaging Modality
2.1.2. Cancer Imaging System Market Snippet by Application
2.1.3. Cancer Imaging System Market Snippet by End-user
2.1.4. Cancer Imaging System Market Snippet by Country
2.1.5. Cancer Imaging System Market Snippet by Region
2.2. Competitive Insights
3. Cancer Imaging System Key Market Trends
3.1. Cancer Imaging System Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Cancer Imaging System Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Cancer Imaging System Market Opportunities
3.4. Cancer Imaging System Market Future Trends
4. Cancer Imaging System Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Cancer Imaging System Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Cancer Imaging System Market Landscape
6.1. Cancer Imaging System Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Cancer Imaging System Market – By Imaging Modality
7.1. Overview
7.1.1. Segment Share Analysis, By Imaging Modality, 2024 & 2032 (%)
7.1.2. Magnetic Resonance Imaging (MRI)
7.1.3. Computed Tomography (CT)
7.1.4. Positron Emission Tomography (PET)
7.1.5. Ultrasound
7.1.6. Mammography
7.1.7. Others
8. Cancer Imaging System Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
8.1.2. Breast Cancer
8.1.3. Lung Cancer
8.1.4. Colorectal Cancer
8.1.5. Prostate Cancer
8.1.6. Liver Cancer
8.1.7. Others
9. Cancer Imaging System Market – By End-user
9.1. Overview
9.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
9.1.2. Hospitals
9.1.3. Diagnostic Imaging Centers
9.1.4. Specialty Clinics
9.1.5. Academic and Research Institutes
10. Cancer Imaging System Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Cancer Imaging System Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Cancer Imaging System Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. UK Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.8.5. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. France Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.9.5. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. Italy Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.10.5. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.3. Spain Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.11.5. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.3. The Netherlands Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.12.5. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.13.5. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.3. Russia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.14.5. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.15.5. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.16.5. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Cancer Imaging System Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. APAC Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.6. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. China Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.7.5. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. India Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.8.5. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Indonesia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.12.5. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Thailand Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.13.5. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. Cancer Imaging System Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. LATAM Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.6. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. Cancer Imaging System Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. MEA Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.6. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. UAE Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.8.5. UAE Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Cancer Imaging System Industry
11.1. Competitive Dashboard
11.1.1. Competitive Benchmarking
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. GE HealthCare
11.2.2. Siemens Healthineers
11.2.3. Philips Healthcare
11.2.4. Canon Medical Systems
11.2.5. Fujifilm Holdings
11.2.6. Hologic Inc.
11.2.7. Bracco Imaging
11.2.8. Carestream Health
11.2.9. Esaote SpA
11.2.10. Shimadzu Corporation
11.2.11. Samsung Medison
11.2.12. United Imaging Healthcare
11.2.13. PerkinElmer Inc.
11.2.14. Agfa-Gevaert Group
11.2.15. Konica Minolta Healthcare
11.2.16. Mindray Medical International
11.2.17. Neusoft Medical Systems
11.2.18. ViewRay Inc.
11.2.19. Hyperfine Inc.
11.2.20. Median Technologies
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
